- Home
- IBG vs BDRX Comparison
IBG vs BDRX Comparison
Compare IBG & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBG
- BDRX
- Stock Information
- Founded
- IBG 2018
- BDRX 2000
- Country
- IBG Australia
- BDRX United Kingdom
- Employees
- IBG N/A
- BDRX N/A
- Industry
- IBG Beverages (Production/Distribution)
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- IBG Consumer Staples
- BDRX Health Care
- Exchange
- IBG Nasdaq
- BDRX Nasdaq
- Market Cap
- IBG 4.1M
- BDRX 3.6M
- IPO Year
- IBG 2024
- BDRX N/A
- Fundamental
- Price
- IBG $0.54
- BDRX $1.15
- Analyst Decision
- IBG Strong Buy
- BDRX
- Analyst Count
- IBG 1
- BDRX 0
- Target Price
- IBG N/A
- BDRX N/A
- AVG Volume (30 Days)
- IBG 130.1K
- BDRX 3.6M
- Earning Date
- IBG 06-17-2025
- BDRX 04-11-2025
- Dividend Yield
- IBG N/A
- BDRX N/A
- EPS Growth
- IBG N/A
- BDRX N/A
- EPS
- IBG N/A
- BDRX N/A
- Revenue
- IBG $2,931,243.00
- BDRX N/A
- Revenue This Year
- IBG N/A
- BDRX N/A
- Revenue Next Year
- IBG N/A
- BDRX N/A
- P/E Ratio
- IBG N/A
- BDRX N/A
- Revenue Growth
- IBG N/A
- BDRX N/A
- 52 Week Low
- IBG $0.44
- BDRX $1.01
- 52 Week High
- IBG $3.35
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- IBG N/A
- BDRX 39.66
- Support Level
- IBG N/A
- BDRX $1.01
- Resistance Level
- IBG N/A
- BDRX $1.26
- Average True Range (ATR)
- IBG 0.00
- BDRX 0.12
- MACD
- IBG 0.00
- BDRX 0.01
- Stochastic Oscillator
- IBG 0.00
- BDRX 15.22
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.